214 related articles for article (PubMed ID: 3569310)
21. Effectiveness of propranolol added to a type I antiarrhythmic agent for sustained ventricular tachycardia secondary to coronary artery disease.
Friehling TD; Lipshutz H; Marinchak RA; Stohler JL; Kowey PR
Am J Cardiol; 1990 Jun; 65(20):1328-33. PubMed ID: 2343820
[TBL] [Abstract][Full Text] [Related]
22. Discordance between ambulatory monitoring and programmed stimulation in assessing efficacy of class IA antiarrhythmic agents in patients with ventricular tachycardia.
Kim SG; Seiden SW; Matos JA; Waspe LE; Fisher JD
J Am Coll Cardiol; 1985 Sep; 6(3):539-44. PubMed ID: 2411776
[TBL] [Abstract][Full Text] [Related]
23. Electropharmacologic testing in sustained ventricular tachycardia associated with coronary heart disease: value of the response to intravenous procainamide in predicting the response to oral procainamide and oral quinidine treatment.
Oseran DS; Gang ES; Rosenthal ME; Mandel WJ; Peter T
Am J Cardiol; 1985 Nov; 56(13):883-6. PubMed ID: 3904387
[TBL] [Abstract][Full Text] [Related]
24. Torsade de pointes ventricular tachycardia. A complication of disopyramide shared with quinidine.
Wald RW; Waxman MB; Colman JM
J Electrocardiol; 1981 Jul; 14(3):301-7. PubMed ID: 7264507
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of the response to intravenous procainamide during electrophysiologic study in predicting the response to oral quinidine in patients with inducible sustained monomorphic ventricular tachycardia associated with coronary artery disease.
Pires LA; Wagshal AB; Greene TO; Mittleman RS; Huang SK
Am J Cardiol; 1993 Oct; 72(12):908-10. PubMed ID: 8105674
[TBL] [Abstract][Full Text] [Related]
26. [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
Raviele A; Di Pede F; Delise P; Piccolo E
G Ital Cardiol; 1984 Sep; 14(9):644-54. PubMed ID: 6510619
[TBL] [Abstract][Full Text] [Related]
27. Electrocardiographic correlates of spontaneous termination of ventricular tachycardia in patients with coronary artery disease.
Duff HJ; Mitchell LB; Gillis AM; Sheldon RS; Chudleigh L; Cassidy P; Chiamvimonvat N; Wyse DG
Circulation; 1993 Sep; 88(3):1054-62. PubMed ID: 8353867
[TBL] [Abstract][Full Text] [Related]
28. In silico assessment of the effects of quinidine, disopyramide and E-4031 on short QT syndrome variant 1 in the human ventricles.
Luo C; Wang K; Zhang H
PLoS One; 2017; 12(6):e0179515. PubMed ID: 28632743
[TBL] [Abstract][Full Text] [Related]
29. Resistant ventricular tachycardias and recurrent cardiac arrests. 96 episodes.
Harner RH; Boyd RB
Chest; 1977 Mar; 71(3):426-9. PubMed ID: 837764
[TBL] [Abstract][Full Text] [Related]
30. Periodic changes in cycle length of ventricular tachycardia: a Wenckebach type exit block?
Aizawa Y; Funazaki T; Satoh M; Suzuki K; Aizawa M; Shibata A
J Electrocardiol; 1986 Oct; 19(4):389-92. PubMed ID: 2432142
[TBL] [Abstract][Full Text] [Related]
31. Intravenous quinidine: relations among concentration, tachyarrhythmia suppression and electrophysiologic actions with inducible sustained ventricular tachycardia.
Duff HJ; Wyse DG; Manyari D; Mitchell LB
Am J Cardiol; 1985 Jan; 55(1):92-7. PubMed ID: 3966404
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the antiarrhythmic efficacy of disopyramide and mexiletine against stimulus-induced ventricular tachycardia.
Breithardt G; Seipel L; Abendroth RR
J Cardiovasc Pharmacol; 1981; 3(5):1026-37. PubMed ID: 6168848
[TBL] [Abstract][Full Text] [Related]
33. The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications.
Waxman HL; Buxton AE; Sadowski LM; Josephson ME
Circulation; 1983 Jan; 67(1):30-7. PubMed ID: 6847803
[TBL] [Abstract][Full Text] [Related]
34. Proarrhythmic effects of antiarrhythmic drugs during programmed ventricular stimulation in patients without ventricular tachycardia.
Au PK; Bhandari AK; Bream R; Schreck D; Siddiqi R; Rahimtoola SH
J Am Coll Cardiol; 1987 Feb; 9(2):389-97. PubMed ID: 2433319
[TBL] [Abstract][Full Text] [Related]
35. Procainamide in the induction and perpetuation of ventricular tachycardia in man.
Kang PS; Gomes JA; El-Sherif N
Pacing Clin Electrophysiol; 1982 May; 5(3):311-22. PubMed ID: 6179048
[TBL] [Abstract][Full Text] [Related]
36. Intravenous disopyramide phosphate and ventricular overdrive pacing in the termination of paroxysmal ventricular tachycardia.
Camm J; Ward D; Washington HG; Spurrell RA
Pacing Clin Electrophysiol; 1979 Jul; 2(4):395-402. PubMed ID: 95308
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of the efficacy of 2 delayed-action preparations of hydroquinidine and quinidine in the prevention of pacing induced ventricular tachycardia].
Lévy S; Moyal C; Dolla E; Cointe R; Bru P; Lauribe P; Paganelli F; Chanu P; Gérard R
Arch Mal Coeur Vaiss; 1993 Sep; 86(9):1359-63. PubMed ID: 8129554
[TBL] [Abstract][Full Text] [Related]
38. Randomized controlled trial of prophylactic antiarrhythmic therapy in patients with inducible ventricular tachyarrhythmias after recent myocardial infarction.
Denniss AR; Ross DL; Cody DV; Russell PA; Young AA; Richards DA; Uther JB
Eur Heart J; 1988 Jul; 9(7):746-57. PubMed ID: 3169044
[TBL] [Abstract][Full Text] [Related]
39. Effects of incremental doses of procainamide in patients with sustained uniform ventricular tachycardia.
Grimm W; Cho JG; Marchlinski FE
J Cardiovasc Electrophysiol; 1994 Apr; 5(4):313-22. PubMed ID: 8019707
[TBL] [Abstract][Full Text] [Related]
40. Utility of the signal-averaged electrocardiogram in patients presenting with sustained ventricular tachycardia or fibrillation while on an antiarrhythmic drug.
Nalos PC; Gang ES; Mandel WJ; Myers MR; Oseran DS; Lass Y; Peter T
Am Heart J; 1988 Jan; 115(1 Pt 1):108-14. PubMed ID: 3336965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
